Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03000660
Recruitment Status : Suspended (partial clinical hold per FDA)
First Posted : December 22, 2016
Last Update Posted : May 3, 2019
Sponsor:
Information provided by (Responsible Party):
Tufts Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : January 2021